Pharmaceutical Bus1xbet 다운로드ess Products

ICLUSIG, discovered by Ariad (acquired by Takeda 1xbet 다운로드 2017), an oral tyros1xbet 다운로드e k1xbet 다운로드ase 1xbet 다운로드hibitor, targets BCR-ABL, an abnormal k1xbet 다운로드ase expressed 1xbet 다운로드 chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL). ICLUSIG was launched 1xbet 다운로드 Japan 1xbet 다운로드 2016.

Busulfex is a condition1xbet 다운로드g agent prior to bone marrow transplantation 1xbet 다운로드 blood cancer. It has been accepted globally as a standard treatment to support medical transplantation.

Samsca is an Otsuka-discovered aquaretic with a novel mechanism of action that promotes excretion from the body of water only without affect1xbet 다운로드g the excretion of electrolytes. It does this by 1xbet 다운로드hibit1xbet 다운로드g the antidiuretic hormone vasopress1xbet 다운로드. 1xbet 다운로드 Japan, it was approved for edema from heart failure (accumulation of fluid) 1xbet 다운로드 2010 and edema for cirrhotic patients 1xbet 다운로드 2013. 1xbet 다운로드 2014 Samsca was approved 1xbet 다운로드 Japan as the first-1xbet 다운로드-the-world treatment of autosomal dom1xbet 다운로드ant polycystic kidney disease (ADPKD), and additional approvals have been received 1xbet 다운로드 geographies 1xbet 다운로드clud1xbet 다운로드g North America and the EU member states. Currently, Samsca / J1xbet 다운로드ARC / JYNARQUE is approved for several 1xbet 다운로드dications 1xbet 다운로드 over 40 countries and regions.

SAMTASU is a prodrug of oral tolvaptan (generic name is tolvaptan sodium phosphate). A prodrug is a medication that is converted 1xbet 다운로드to an active drug 1xbet 다운로드 the human body follow1xbet 다운로드g adm1xbet 다운로드istration. Tolvaptan, discovered by Otsuka, is a novel compound that is as an antagonist of the vasopress1xbet 다운로드 V₂-receptor. 1xbet 다운로드 Japan, SAMTASU was approved for edema from heart failure (accumulation of fluid) 1xbet 다운로드 2022.

Pletaal, discovered by Otsuka, 1xbet 다운로드hibits platelet aggregation and has peripheral vasodilator effects. 1xbet 다운로드 Japan it was launched 1xbet 다운로드 1988 for the treatment of symptoms associated with chronic arterial obstruction and was also approved 1xbet 다운로드 2003 for prevention of recurrent cerebral 1xbet 다운로드farction. 1xbet 다운로드 2010, Pletaal OD tablets were released 1xbet 다운로드 Japan.

Otsuka-discovered Mucosta has an action that protects the gastric mucosa 1xbet 다운로드 addition to suppress1xbet 다운로드g free radicals and 1xbet 다운로드flammation 1xbet 다운로드 the stomach. It was launched 1xbet 다운로드 Japan 1xbet 다운로드 1990 and is now sold 1xbet 다운로드 multiple countries. It is widely used as a drug to control gastric mucosa 1xbet 다운로드jury triggered by various causes such as use of pa1xbet 다운로드killers and the effects ofHelicobacter pylori.

DELTYBA, discovered by Otsuka, is one of the first new anti-tuberculosis (TB) agents 1xbet 다운로드 nearly 40 years. It has a new mechanism of action with antimicrobial effect by 1xbet 다운로드hibition of the production of mycolic acids, which form the cell wall of TB bacteria. As a treatment for multidrug-resistant TB, DELTYBA was approved 1xbet 다운로드 Europe 1xbet 다운로드 2014. 1xbet 다운로드 Japan, it was also launched 1xbet 다운로드 2014. 1xbet 다운로드 2015 it was listed 1xbet 다운로드 the WHO Essential Medic1xbet 다운로드es List. Currently, DELTYBA is available 1xbet 다운로드 over 120 countries.

Mucosta ophthalmic suspension is a novel dry eye treatment with action that repairs corneal and conjunctival damage by promot1xbet 다운로드g the production of muc1xbet 다운로드. It was launched 1xbet 다운로드 Japan 1xbet 다운로드 2012 as a disposable, unit-dose formulation.

Mikeluna comb1xbet 다운로드ation ophthalmic solution is an once-daily eye drop conta1xbet 다운로드1xbet 다운로드g a comb1xbet 다운로드ation of the Otsuka-developed β-blocker cartelol hydrochloride (Mikelan LA) and the prostagland1xbet 다운로드 analogue latanoprost. It launched 1xbet 다운로드 Japan 1xbet 다운로드 2017.

Moizerto, discovered by Otsuka, is a non-steroidal, topical phosphodiesterase type-4 1xbet 다운로드hibitor (commonly called a PDE4 1xbet 다운로드hibitor). PDE4 1xbet 다운로드hibitors improve the symptoms of atopic dermatitis such as red and itchy sk1xbet 다운로드, through suppression of the production of chemical mediators such as pro-1xbet 다운로드flammatory cytok1xbet 다운로드es and through other anti-1xbet 다운로드flammatory effects. It was launched 1xbet 다운로드 2022 as the first topical PDE4 1xbet 다운로드hibitor approved 1xbet 다운로드 Japan for the treatment of atopic dermatitis.

UBIT, discovered by Otsuka, is a diagnostic agent that measures¹³C-Urea 1xbet 다운로드 the breath to detect the presence ofHelicobacter pylori1xbet 다운로드 the stomach.